Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in Diabetologia Retrieve available abstracts of 364 articles: HTML format

Single Articles

October 2025
1. MA C, Zeng H
   Methodological considerations for interpreting long-term statin use and diabetes incidence.
   Diabetologia. 2025 Oct 9. doi: 10.1007/s00125-025-06568.
   PubMed    
   
   
   
2. O'CONNELL MA, Beare R, Messazos B, Northam EA, et al
   Acute brain responses to hypoglycaemia and hyperglycaemia in adolescents with type 1 diabetes.
   Diabetologia. 2025 Oct 7. doi: 10.1007/s00125-025-06548.
   PubMed     Abstract available
   
   
   
3. SLOAN G, Teh K, Greig M, Shillo P, et al
   Beyond pain relief: the effects of chronic opioid use on brain structure and function in diabetic neuropathy-a multimodal neuroimaging study.
   Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06529.
   PubMed     Abstract available
   
   
   
4. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
   No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
   Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06562.
   PubMed    
   
   
   
5. FADINI GP
   No evidence that tirzepatide can worsen diabetic retinopathy.
   Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06564.
   PubMed    
   
   
   
6. ZHANG Y, Giovannucci EL, Wang DD
   Methodological considerations for interpreting long-term statin use and diabetes incidence. Reply to Ma C, Zeng H [letter].
   Diabetologia. 2025 Oct 3. doi: 10.1007/s00125-025-06569.
   PubMed    
   
   
   
7. MICHALEK DA, Tern C, Robertson CC, Chen WM, et al
   HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry.
   Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06563.
   PubMed     Abstract available
   
   
   
8. PAPADIMOS ER, Claussen C, Magliano DJ, Hotu C, et al
   Prevalence of youth type 2 diabetes in global Indigenous populations: a systematic review.
   Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06556.
   PubMed     Abstract available
   
   
   
9. ALBARGOTHY MJ, Troendle EP, Laws R, Barabas P, et al
   3D electron microscopy reveals novel ultrastructural changes in the diabetic retinal neurovascular unit.
   Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06554.
   PubMed     Abstract available
   
   
   
10. WHELEHAN G, Hakim O, Ladwa M, Bello O, et al
    Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance.
    Diabetologia. 2025;68:2290-2295.
    PubMed     Abstract available
    
    
    
11. ANDERSEN AK, Lyng KD, Faerch K, Vistisen D, et al
    What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers.
    Diabetologia. 2025;68:2156-2167.
    PubMed     Abstract available
    
    
    
12. ZHANG RX, Li AQ, Zhao XY, Wang B, et al
    Identification of SEC16B as a novel regulator of glucose homeostasis.
    Diabetologia. 2025;68:2247-2262.
    PubMed     Abstract available
    
    
    
13. MARUCCI A, Derhourhi M, Menzaghi C, Fini G, et al
    The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.
    Diabetologia. 2025;68:2240-2246.
    PubMed     Abstract available
    
    
    
14. DENG Y, Wu H, Ng NYH, Tam CHT, et al
    Association between maternal glucose levels in pregnancy and offspring's metabolism and adiposity: an 18-year birth cohort study.
    Diabetologia. 2025;68:2205-2216.
    PubMed     Abstract available
    
    
    September 2025
15. TRIMBLE ER, Phillips DIW, Balcha SA
    Phenotype of insulin-dependent diabetes in chronic undernutrition: beta cell stress and immune dysfunction-a rural sub-Saharan perspective on type 5 diabetes.
    Diabetologia. 2025 Sep 29. doi: 10.1007/s00125-025-06553.
    PubMed     Abstract available
    
    
    
16. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Correction: Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Sep 27. doi: 10.1007/s00125-025-06557.
    PubMed    
    
    
    
17. CASTELBLANCO E, Shyr ZA, Ramirez-Sotero I, Yan Z, et al
    Restoration of pancreatic beta cell identity and autophagy in K(ATP)-induced diabetes by intermittent fasting.
    Diabetologia. 2025 Sep 25. doi: 10.1007/s00125-025-06545.
    PubMed     Abstract available
    
    
    
18. DYSON NJ, Kattner N, Al-Selwi Y, Honkanen-Scott M, et al
    Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06547.
    PubMed     Abstract available
    
    
    
19. TOLEDO FGS, Li Y, Wang F, Bellin MD, et al
    Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06543.
    PubMed     Abstract available
    
    
    
20. KVIST AAS, Sharma A, Qvigstad E, Sattar N, et al
    Differences in tissue-specific insulin resistance between South Asian and Nordic women with prediabetes after gestational diabetes.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06546.
    PubMed     Abstract available
    
    
    
21. HOYER KL, Kornum DS, Baunwall SMD, Klinge MW, et al
    Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544.
    PubMed     Abstract available
    
    
    
22. DIETLER D, Bjork J, Palmkvist E, Carlsson A, et al
    Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in Sweden.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06540.
    PubMed     Abstract available
    
    
    
23. GIORGINO F, Alzaid F, Pantea Stoian A, Chan JCN, et al
    Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.
    Diabetologia. 2025 Sep 10. doi: 10.1007/s00125-025-06504.
    PubMed     Abstract available
    
    
    
24. CANHA D, Choudhary P, Cosson E, Banu I, et al
    Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes-the critical role of hypoglycaemia awareness: results from the SFDT1 study.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06536.
    PubMed     Abstract available
    
    
    
25. SUBRAMANIAN V, Sherman AS, Holst JJ, Knop FK, et al
    Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06524.
    PubMed     Abstract available
    
    
    
26. CIVIT-URGELL A, Pena E, Bejar MT, Moscatiello F, et al
    bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06533.
    PubMed     Abstract available
    
    
    
27. GU X, Wei Y
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06531.
    PubMed    
    
    
    
28. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter].
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06532.
    PubMed    
    
    
    
29. PETKOVIC M, Leal EC, Sorensen AE, Jorgensen PT, et al
    Improved wound healing by dual inhibition of miR-146a-5p and miR-29a-3p supports a network action of dysregulated miRNAs in diabetic skin.
    Diabetologia. 2025 Sep 3. doi: 10.1007/s00125-025-06522.
    PubMed     Abstract available
    
    
    
30. MUNGKALASUT P, Chanda M, Jugnam-Ang W, Cheepsunthorn P, et al
    Glucose 6-phosphate dehydrogenase deficiency and Southeast Asian-specific mutations lower HbA(1c) levels in a Thai population: implications for diabetes diagnosis.
    Diabetologia. 2025 Sep 1. doi: 10.1007/s00125-025-06523.
    PubMed     Abstract available
    
    
    
31. GOMEZ-MEDINA AM, Henao-Carillo DC, Villamil-Castaneda LP, Gomez-Quesada Y, et al
    Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial.
    Diabetologia. 2025;68:1899-1907.
    PubMed     Abstract available
    
    
    
32. BRISNOVALI NF, Franco I, Abdelgawwad A, Tsou HLP, et al
    Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels.
    Diabetologia. 2025;68:2042-2056.
    PubMed     Abstract available
    
    
    
33. DIMITROPOULOU NM, Eussen SJPM, Schalkwijk CG, de Galan BE, et al
    Glucose variability measured by continuous glucose monitoring is associated with skin autofluorescence: the Maastricht Study.
    Diabetologia. 2025;68:1937-1946.
    PubMed     Abstract available
    
    
    August 2025
34. JIA X, Wang S, Lin H, Zhu Y, et al
    Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
    Diabetologia. 2025 Aug 30. doi: 10.1007/s00125-025-06528.
    PubMed     Abstract available
    
    
    
35. 
    61(st) EASD Annual Meeting of the European Association for the Study of Diabetes : Vienna, Austria, 15 - 19 September 2025.
    Diabetologia. 2025 Aug 26. doi: 10.1007/s00125-025-06497.
    PubMed    
    
    
    
36. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Aug 21. doi: 10.1007/s00125-025-06520.
    PubMed     Abstract available
    
    
    
37. YU MG, Shah H, Jangolla S, Gauthier J, et al
    Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.
    Diabetologia. 2025 Aug 20. doi: 10.1007/s00125-025-06521.
    PubMed     Abstract available
    
    
    
38. SHI C, Wang X, Qin S, He A, et al
    BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06519.
    PubMed     Abstract available
    
    
    
39. HUHN EA, Kotzaeridi G, Fischer T, Todesco Bernasconi M, et al
    The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06517.
    PubMed     Abstract available
    
    
    
40. SPEKSNIJDER EM, Simsek S, Bisschop PH, Stenvers DJ, et al
    Perceived blood glucose regulation after menopause: a cross-sectional survey in women with type 1 diabetes in the Netherlands.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06518.
    PubMed     Abstract available
    
    
    
41. AUGUSTINE J, Troendle EP, Friedel T, Baldwin C, et al
    Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease.
    Diabetologia. 2025 Aug 15. doi: 10.1007/s00125-025-06515.
    PubMed     Abstract available
    
    
    
42. HERDER C, Pritlove C, Chaturvedi N, Mulder H, et al
    Diabetes prevention and treatment: a global perspective.
    Diabetologia. 2025 Aug 12. doi: 10.1007/s00125-025-06511.
    PubMed    
    
    
    
43. MYTKOLLI L, Ahmed A, Ajmal S, Alvarez Pagola A, et al
    Diabetes in four dialects: a global call for equity across lived, loved, learned and laboured experiences.
    Diabetologia. 2025 Aug 9. doi: 10.1007/s00125-025-06506.
    PubMed    
    
    
    
44. KENNEDY B, Wernroth ML, Langenskiold S, Bonander C, et al
    The impact of child type 1 diabetes on parental incomes in a welfare state context: quasi-experimental evidence from Swedish national registers.
    Diabetologia. 2025 Aug 8. doi: 10.1007/s00125-025-06492.
    PubMed     Abstract available
    
    
    
45. ROTH-SCHULZE AJ, Bandala-Sanchez E, Ngui KM, Naselli G, et al
    Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome.
    Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06509.
    PubMed     Abstract available
    
    
    
46. CHATURVEDI N, Voight BF, Wells JC, Pritlove C, et al
    Race, ethnicity and ancestry in global diabetes research: grappling with complexity to advance equity and scientific integrity - a narrative review and viewpoint.
    Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06516.
    PubMed     Abstract available
    
    
    
47. STENE LC
    Perspectives on prevention of type 1 diabetes and heterogeneities.
    Diabetologia. 2025 Aug 6. doi: 10.1007/s00125-025-06512.
    PubMed     Abstract available
    
    
    
48. YAU B, Ghislain J, Kebede MA, Hughes J, et al
    The role of the beta cell in type 2 diabetes: new findings from the last 5 years.
    Diabetologia. 2025 Aug 6. doi: 10.1007/s00125-025-06499.
    PubMed     Abstract available
    
    
    
49. PARAJULI A, Bendes A, Byvald F, Stone VM, et al
    Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes.
    Diabetologia. 2025 Aug 4. doi: 10.1007/s00125-025-06502.
    PubMed     Abstract available
    
    
    
50. GONG JY, Sajjadi SF, Motala AA, Shaw JE, et al
    Variation in type 2 diabetes prevalence across different populations: the key drivers.
    Diabetologia. 2025 Aug 4. doi: 10.1007/s00125-025-06478.
    PubMed     Abstract available
    
    
    
51. WRIGHT AK, Huang T, Carr MJ, Premdayal AD, et al
    Clinical utility of self-reported sleep duration and insomnia symptoms in type 2 diabetes prediction.
    Diabetologia. 2025 Aug 2. doi: 10.1007/s00125-025-06503.
    PubMed     Abstract available
    
    
    
52. KIM S, Park SH, Lee JA, Cho SH, et al
    Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA(1c) targets.
    Diabetologia. 2025;68:1674-1679.
    PubMed     Abstract available
    
    
    
53. DUTTA A, Dutta PK, Baruah SM, Dihingia P, et al
    Non-autoimmune diabetes in young people from Assam, India: the PHENOEINDY-2 study.
    Diabetologia. 2025 Aug 1. doi: 10.1007/s00125-025-06500.
    PubMed     Abstract available
    
    
    July 2025
54. MUNOZ-PARDEZA J, Lopez-Gil JF, Hormazabal-Aguayo I, Huerta-Uribe N, et al
    Compositional analysis of the association between 24 h movement behaviours, HbA(1c) and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis of the Diactive-1 cohort study.
    Diabetologia. 2025 Jul 31. doi: 10.1007/s00125-025-06496.
    PubMed     Abstract available
    
    
    
55. KALHAN TA, Luo M, Chai JH, Tai ES, et al
    Health economic evaluation of a risk-stratified intervention in diabetic kidney disease.
    Diabetologia. 2025 Jul 30. doi: 10.1007/s00125-025-06498.
    PubMed     Abstract available
    
    
    
56. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
    The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2025 Jul 30. doi: 10.1007/s00125-025-06462.
    PubMed     Abstract available
    
    
    
57. HWANG JJ, Bini J, Belfort-DeAguiar R
    Measurement of brain glucose metabolism in obesity and diabetes.
    Diabetologia. 2025 Jul 25. doi: 10.1007/s00125-025-06491.
    PubMed     Abstract available
    
    
    
58. MORI T, Zaharia OP, Strassburger K, Dennis JM, et al
    Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes.
    Diabetologia. 2025 Jul 25. doi: 10.1007/s00125-025-06486.
    PubMed     Abstract available
    
    
    
59. LUK AOY, Fan Y, Fan B, Chow EWK, et al
    Heterogeneity in the development of diabetes-related complications: narrative review of the roles of ancestry and geographical determinants.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06482.
    PubMed     Abstract available
    
    
    
60. ADDALA A, Amedari MI, Figg LE, Ebekozien O, et al
    Disparities in access to and use of diabetes technologies and therapeutics: a narrative review.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06494.
    PubMed     Abstract available
    
    
    
61. YAMAGUCHI Y, Kuwata H, Imura M, Moyama S, et al
    Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06493.
    PubMed     Abstract available
    
    
    
62. RUSS-SILSBY J, Teles M, Hassan SS, Elbarbary NS, et al
    Global perspectives on monogenic forms of diabetes.
    Diabetologia. 2025 Jul 16. doi: 10.1007/s00125-025-06495.
    PubMed     Abstract available
    
    
    
63. NIELSEN H, Lajeunesse-Trempe F, Lin AL, Nielsen MH, et al
    Societal and biological approaches to diabetes prevention and care for Inuit populations: a narrative review.
    Diabetologia. 2025 Jul 15. doi: 10.1007/s00125-025-06487.
    PubMed     Abstract available
    
    
    
64. DEGROOTE L, Martens PJ, Viaene M, Heremans Y, et al
    Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.
    Diabetologia. 2025 Jul 12. doi: 10.1007/s00125-025-06490.
    PubMed     Abstract available
    
    
    
65. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
    Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study.
    Diabetologia. 2025 Jul 10. doi: 10.1007/s00125-025-06466.
    PubMed     Abstract available
    
    
    
66. GUBELI A, Steiner N, Limacher A, Mathis D, et al
    Dapagliflozin's impact on hormonal regulation and ketogenesis in type 1 diabetes: a randomised controlled crossover trial.
    Diabetologia. 2025 Jul 9. doi: 10.1007/s00125-025-06481.
    PubMed     Abstract available
    
    
    
67. HERDER C, Zhu A, Schmitt A, Spagnuolo MC, et al
    Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters.
    Diabetologia. 2025 Jul 8. doi: 10.1007/s00125-025-06472.
    PubMed     Abstract available
    
    
    
68. XU QH, Huang YJ
    Rethinking the link between gestational diabetes and dementia risk.
    Diabetologia. 2025 Jul 2. doi: 10.1007/s00125-025-06480.
    PubMed    
    
    
    
69. HENRIKSEN K, Rufer C, Title AC, Jawurek S, et al
    Proinflammatory cytokine-induced alpha cell impairment in human islet microtissues is partially restored by dual incretin receptor agonism.
    Diabetologia. 2025;68:1492-1508.
    PubMed     Abstract available
    
    
    
70. MOEN GH, Hwang LD, Brito Nunes C, Warrington NM, et al
    The genetics of low and high birthweight and their relationship with cardiometabolic disease.
    Diabetologia. 2025;68:1452-1462.
    PubMed     Abstract available
    
    
    
71. EHRMANN D, Krause-Steinrauf H, Uschner D, Wen H, et al
    Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.
    Diabetologia. 2025;68:1403-1415.
    PubMed     Abstract available
    
    
    
72. CORBIN LJ, Merino J, Fall T, Herder C, et al
    Raising the bar for publication of Mendelian randomisation studies in Diabetologia.
    Diabetologia. 2025 Jul 1. doi: 10.1007/s00125-025-06484.
    PubMed    
    
    
    June 2025
73. KELLER MJ, Brady AJ, Smith JAB, Savikj M, et al
    Inflammatory markers and blood glucose are higher after morning vs afternoon exercise in type 2 diabetes.
    Diabetologia. 2025 Jun 28. doi: 10.1007/s00125-025-06477.
    PubMed     Abstract available
    
    
    
74. MICHEL M, Flahault A, Coliche V, Alla A, et al
    Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study.
    Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06471.
    PubMed     Abstract available
    
    
    
75. PATEL K, Eastwood SV, Wells JC, Chaturvedi N, et al
    Diabetogenic elevated childhood total fat in South Asian and Black African/Caribbean people relates to adverse early life growth and low socioeconomic position compared with White people in the UK.
    Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06473.
    PubMed     Abstract available
    
    
    
76. HU J, Jiang G, Qin J, Luo S, et al
    A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population.
    Diabetologia. 2025 Jun 26. doi: 10.1007/s00125-025-06455.
    PubMed     Abstract available
    
    
    
77. ABRAMOFF KJ, Maloney SK, Jones TW, Davis EA, et al
    Does exercise in cool water cause a higher risk of hypoglycaemia than in thermoneutral conditions in type 1 diabetes?
    Diabetologia. 2025 Jun 18. doi: 10.1007/s00125-025-06456.
    PubMed     Abstract available
    
    
    
78. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Correction: Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06460.
    PubMed    
    
    
    
79. DENG Y, Tam CHT, Yang A, Shi M, et al
    Association of maternal overweight and gestational diabetes mellitus with offspring adiposity trajectory: from birth to early adolescence.
    Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06468.
    PubMed     Abstract available
    
    
    
80. ZHOU Y, Hu L, Zhuang R, Song L, et al
    METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice.
    Diabetologia. 2025 Jun 10. doi: 10.1007/s00125-025-06459.
    PubMed     Abstract available
    
    
    
81. GUYER P, Seminova K, Lugar M, Manganaro A, et al
    T cell and autoantibody recognition of nucleus-associated islet autoantigens in individuals with type 1 diabetes.
    Diabetologia. 2025 Jun 9. doi: 10.1007/s00125-025-06458.
    PubMed     Abstract available
    
    
    
82. BENNET L, Agyemang C
    Prevention of type 2 diabetes in migrant populations from low- and middle-income countries living in high-income countries.
    Diabetologia. 2025 Jun 7. doi: 10.1007/s00125-025-06465.
    PubMed     Abstract available
    
    
    
83. COSTABILE G, Salamone D, Della Pepa G, Testa R, et al
    ApoC-III and ectopic fat accumulation in individuals with type 2 diabetes: an exploratory analysis from the MEDEA randomised controlled study.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06464.
    PubMed     Abstract available
    
    
    
84. DEKKER E, de Winter TJJ, Munoz Garcia A, de Graaf N, et al
    BMP5 signalling in beta cells and the impact on insulin secretion in the context of type 2 diabetes.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06457.
    PubMed     Abstract available
    
    
    
85. KUO CC, Chuang MH, Li CH, Tsai YW, et al
    Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06453.
    PubMed     Abstract available
    
    
    
86. ALZAID F, Fagherazzi G, Riveline JP, Bahman F, et al
    Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes.
    Diabetologia. 2025 Jun 4. doi: 10.1007/s00125-025-06437.
    PubMed     Abstract available
    
    
    
87. EL TOBGY NA, Grewal EK, Gonzalez PM, Tibebu T, et al
    Interventions to improve diabetes care and self-management for individuals experiencing homelessness: a scoping review with systematic search of qualitative and quantitative literature.
    Diabetologia. 2025 Jun 3. doi: 10.1007/s00125-025-06449.
    PubMed     Abstract available
    
    
    
88. SWENSEN AC, Piehowski PD, Chen J, Chan XY, et al
    Increased inflammation as well as decreased endoplasmic reticulum stress and translation differentiate pancreatic islets from donors with pre-symptomatic stage 1 type 1 diabetes and non-diabetic donors.
    Diabetologia. 2025 Jun 2. doi: 10.1007/s00125-025-06417.
    PubMed     Abstract available
    
    
    
89. KALE A, Azar M, Cheng V, Robertson H, et al
    Regulating islet stress responses through CD47 activation.
    Diabetologia. 2025;68:1279-1297.
    PubMed     Abstract available
    
    
    
90. CHEBII VJ, Wade AN, Crowther NJ, Nonterah EA, et al
    Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort.
    Diabetologia. 2025;68:1184-1196.
    PubMed     Abstract available
    
    
    May 2025
91. O'NEILL S, Bidulka P, Lugo-Palacios DG, Carroll O, et al
    Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.
    Diabetologia. 2025 May 31. doi: 10.1007/s00125-025-06447.
    PubMed     Abstract available
    
    
    
92. MARTINENGHI S, Merolla A, Grogan P, Bianconi E, et al
    Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy.
    Diabetologia. 2025 May 29. doi: 10.1007/s00125-025-06461.
    PubMed     Abstract available
    
    
    
93. HOLT RIG, Tsapas A, Meireles M, Mulder H, et al
    Clinical guidelines and other guidance from the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06378.
    PubMed    
    
    
    
94. MEIRELES M, Holt RIG, Tsapas A, Mulder H, et al
    The new era of European Association for the Study of Diabetes (EASD) clinical guidance documents.
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06452.
    PubMed    
    
    
    
95. KARAGIANNIS T, Advani A, Davies MJ, Del Prato S, et al
    European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines.
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06370.
    PubMed     Abstract available
    
    
    
96. HENI M, Fruhwald L, Karges W, Naudorf M, et al
    Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study.
    Diabetologia. 2025 May 22. doi: 10.1007/s00125-025-06448.
    PubMed     Abstract available
    
    
    
97. MOLLER PM, Kjobsted R, Petersen MH, de Almeida ME, et al
    Effect of acute exercise and exercise training on the ability of insulin to clear branched-chain amino acids from plasma in obesity and type 2 diabetes.
    Diabetologia. 2025 May 22. doi: 10.1007/s00125-025-06454.
    PubMed     Abstract available
    
    
    
98. GOULDING RP, Charlton BT, Breedveld EA, Huijts JY, et al
    Skeletal muscle mitochondrial health in type 1 diabetes: the role of exercise capacity and lifestyle factors.
    Diabetologia. 2025 May 21. doi: 10.1007/s00125-025-06451.
    PubMed     Abstract available
    
    
    
99. FERRAT LA, Templeman EL, Steck AK, Parikh HM, et al
    Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter.
    Diabetologia. 2025 May 10. doi: 10.1007/s00125-025-06434.
    PubMed     Abstract available
    
    
    
100. LINGVAY I, Benamar M, Chen L, Fu A, et al
     Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
     Diabetologia. 2025 May 5. doi: 10.1007/s00125-025-06435.
     PubMed    
     
     
     
101. LIM CE, Pasternak B, Eliasson B, Ueda P, et al
     Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes.
     Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06439.
     PubMed     Abstract available
     
     
     
102. TAYLOR R
     Aetiology of type 2 diabetes: an experimental medicine odyssey.
     Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06428.
     PubMed     Abstract available
     
     
     
103. ZHANG Y, Li Y, Liu Y, Willett WC, et al
     Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts.
     Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06441.
     PubMed     Abstract available
     
     
     
104. CIANGURA C, Seco A, Saint-Martin C, Ancel PY, et al
     Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities.
     Diabetologia. 2025;68:981-992.
     PubMed     Abstract available
     
     
     April 2025
105. SAGAR RC, Yates DM, Pearson SM, Kietsiriroje N, et al
     Insulin resistance in type 1 diabetes is a key modulator of platelet hyperreactivity.
     Diabetologia. 2025 Apr 30. doi: 10.1007/s00125-025-06429.
     PubMed     Abstract available
     
     
     
106. ADESHARA K, Parente EB, Harjutsalo V, Lehto M, et al
     Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.
     Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440.
     PubMed     Abstract available
     
     
     
107. PURVIS GSD, Chiazza F, Chen J, Azevedo-Loiola R, et al
     Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
     Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06418.
     PubMed    
     
     
     
108. LEWIS CTA, Moreno-Justicia R, Savoure L, Calvo E, et al
     Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus.
     Diabetologia. 2025 Apr 28. doi: 10.1007/s00125-025-06436.
     PubMed     Abstract available
     
     
     
109. EEG-OLOFSSON K, Nathanson D, Spelman T, Kyhlstedt M, et al
     Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring.
     Diabetologia. 2025 Apr 24. doi: 10.1007/s00125-025-06438.
     PubMed     Abstract available
     
     
     
110. ZHOU J, Mychaleckyj JC, Onengut-Gumuscu S, Orchard TJ, et al
     DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study.
     Diabetologia. 2025 Apr 23. doi: 10.1007/s00125-025-06427.
     PubMed     Abstract available
     
     
     
111. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
     The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II.
     Diabetologia. 2025 Apr 21. doi: 10.1007/s00125-025-06430.
     PubMed     Abstract available
     
     
     
112. BOULTON AJM, Jenkins AJ, Makkar B, Mankovsky B, et al
     Diabetes and natural and man-made disasters: prevention, preparation, response and recovery.
     Diabetologia. 2025 Apr 15. doi: 10.1007/s00125-025-06406.
     PubMed     Abstract available
     
     
     
113. ZAPARDIEL-GONZALO J, Ziegler AG, Bonifacio E
     The genetic architecture of type 1 diabetes over time: how well can we rely on past data to predict the future?
     Diabetologia. 2025 Apr 12. doi: 10.1007/s00125-025-06422.
     PubMed    
     
     
     
114. SCHAIN M, Johansson E, Laitinen I, Froden Lowenmark A, et al
     Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-epsilon4.
     Diabetologia. 2025 Apr 11. doi: 10.1007/s00125-025-06405.
     PubMed     Abstract available
     
     
     
115. BANGSHAAB M, Svart MV, Rittig N, Pedersen MGB, et al
     Metabolic effects of 3-hydroxybutyrate infusion in individuals with type 1 diabetes compared with healthy control participants: a randomised crossover trial showing intact feedback suppression of lipolysis.
     Diabetologia. 2025 Apr 10. doi: 10.1007/s00125-025-06423.
     PubMed     Abstract available
     
     
     
116. PRASAD RB, Hakaste L, Tuomi T
     Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.
     Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419.
     PubMed     Abstract available
     
     
     
117. VELMURUGAN S, Pandey VK, Verma N, Kotiya D, et al
     Cardiac remodelling, recognition memory deficits and accelerated ageing in a rat model of gestational diabetes.
     Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06421.
     PubMed     Abstract available
     
     
     
118. RIDDELL MC, Heller S, Carstensen L, Rocha TMP, et al
     The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5.
     Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06414.
     PubMed     Abstract available
     
     
     March 2025
119. KAYA S, Khamees A, Geerling G, Strzalkowski P, et al
     Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes.
     Diabetologia. 2025 Mar 31. doi: 10.1007/s00125-025-06407.
     PubMed     Abstract available
     
     
     
120. MONTGOMERY MK, Lin S, Yang CH, Prasad K, et al
     HEXA-FC protein therapy increases skeletal muscle glucose uptake and improves glycaemic control in mice with insulin resistance and in a mouse model of type 2 diabetes.
     Diabetologia. 2025 Mar 29. doi: 10.1007/s00125-025-06413.
     PubMed     Abstract available
     
     
     
121. DELIYANTI D, Suphapimol V, Joglekar A, Jayasimhan A, et al
     Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3(+) Tregs and CD8(+) T cells.
     Diabetologia. 2025 Mar 25. doi: 10.1007/s00125-025-06412.
     PubMed     Abstract available
     
     
     
122. MORIERI ML, Rigato M, Frison V, D'Ambrosio M, et al
     Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study.
     Diabetologia. 2025 Mar 22. doi: 10.1007/s00125-025-06402.
     PubMed     Abstract available
     
     
     
123. BONIFACIO E, Coelho R, Ewald DA, Gemulla G, et al
     The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes.
     Diabetologia. 2025 Mar 19. doi: 10.1007/s00125-025-06408.
     PubMed     Abstract available
     
     
     
124. LAIHO JE, Oikarinen S, Morfopoulou S, Oikarinen M, et al
     Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes.
     Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06359.
     PubMed     Abstract available
     
     
     
125. RODRIGUEZ-CALVO T, Laiho JE, Oikarinen M, Akhbari P, et al
     Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes.
     Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06384.
     PubMed     Abstract available
     
     
     
126. RICHARDSON SJ, Rodriguez-Calvo T, Laiho JE, Kaddis JS, et al
     Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue.
     Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06401.
     PubMed     Abstract available
     
     
     
127. LEE H, Fernandes M, Lee J, Merino J, et al
     Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications.
     Diabetologia. 2025 Mar 15. doi: 10.1007/s00125-025-06403.
     PubMed     Abstract available
     
     
     
128. YANG Q, Zhu PW, Wen YJ, Zhang R, et al
     MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner.
     Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06398.
     PubMed     Abstract available
     
     
     
129. PITT M, Olvera-Barrios A, Anderson J, Bolter L, et al
     A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.
     Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06379.
     PubMed     Abstract available
     
     
     
130. ZHANG N, Sun Q, Zhang J, Zhang R, et al
     Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes.
     Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06392.
     PubMed     Abstract available
     
     
     
131. SORENSEN KV, Justesen JM, Angquist L, Bork-Jensen J, et al
     Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA(1c) levels but not with type 2 diabetes.
     Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06381.
     PubMed     Abstract available
     
     
     
132. ZURIAGA MA, Fuster JJ
     Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complications.
     Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06393.
     PubMed     Abstract available
     
     
     
133. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
     Correction: Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
     Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06404.
     PubMed    
     
     
     
134. TSOI AT, Sng J, Tummanapalli SS, Issar T, et al
     Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes.
     Diabetologia. 2025 Mar 7. doi: 10.1007/s00125-025-06399.
     PubMed     Abstract available
     
     
     
135. YIN W, Zou S, Sha M, Sun L, et al
     Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress.
     Diabetologia. 2025;68:629-645.
     PubMed     Abstract available
     
     
     
136. REDONDO MJ, Cuthbertson D, Steck AK, Herold KC, et al
     Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes.
     Diabetologia. 2025;68:588-601.
     PubMed     Abstract available
     
     
     
137. MORALES DD, Ryu J, Wei C, Hadley JT, et al
     Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells.
     Diabetologia. 2025;68:615-628.
     PubMed     Abstract available
     
     
     
138. WANG Q, Leask MP, Lee K, Jaiswal J, et al
     The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice.
     Diabetologia. 2025;68:537-548.
     PubMed     Abstract available
     
     
     February 2025
139. MOULDER R, Hirvonen MK, Valikangas T, Suomi T, et al
     Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.
     Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06394.
     PubMed     Abstract available
     
     
     
140. KOFOD DH, Diederichsen SZ, Bomholt T, Andersen MO, et al
     Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study.
     Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06388.
     PubMed     Abstract available
     
     
     
141. SIMS EK, Cuthbertson D, Ferrat LA, Bosi E, et al
     IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes.
     Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06382.
     PubMed     Abstract available
     
     
     
142. DING S, Xu JL, Tong JY, Cheng YY, et al
     Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease.
     Diabetologia. 2025 Feb 27. doi: 10.1007/s00125-025-06385.
     PubMed     Abstract available
     
     
     
143. VERSCHUEREN VAN REES N, Ashwin P, McMullan C, Krogvold L, et al
     Beyond the loss of beta cells: a quantitative analysis of islet architecture in adults with and without type 1 diabetes.
     Diabetologia. 2025 Feb 26. doi: 10.1007/s00125-025-06376.
     PubMed     Abstract available
     
     
     
144. CARLSSON PO, Espes D, Sisay S, Davies LC, et al
     Correction: Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
     Diabetologia. 2025 Feb 25. doi: 10.1007/s00125-025-06371.
     PubMed    
     
     
     
145. XIAO Q, Feng Q, Rutter MK, Albalak G, et al
     Associations between the timing of 24 h physical activity and diabetes mellitus: results from a nationally representative sample of the US population.
     Diabetologia. 2025 Feb 21. doi: 10.1007/s00125-025-06368.
     PubMed     Abstract available
     
     
     
146. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
     Islet autoantibodies in Thai individuals individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
     Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-025-06373.
     PubMed     Abstract available
     
     
     
147. VENKATARAGHAVAN S, Pankow JS, Boerwinkle E, Fornage M, et al
     Epigenome-wide association study of incident type 2 diabetes in Black and White participants from the Atherosclerosis Risk in Communities Study.
     Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-024-06352.
     PubMed     Abstract available
     
     
     
148. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
     How should we define subtypes of gestational diabetes mellitus? Reply to Gobl C, Tura A [letter].
     Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06375.
     PubMed    
     
     
     
149. GOBL C, Tura A
     How should we define subtypes of gestational diabetes mellitus?
     Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06374.
     PubMed    
     
     
     
150. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
     Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
     Diabetologia. 2025 Feb 12. doi: 10.1007/s00125-024-06350.
     PubMed    
     
     
     
151. KORNUM DS, Krogh K, Keller J, Malagelada C, et al
     Diabetic gastroenteropathy: a pan-alimentary complication.
     Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06365.
     PubMed     Abstract available
     
     
     
152. CALHOUN P, Spanbauer C, Steck AK, Frohnert BI, et al
     Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development.
     Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06362.
     PubMed     Abstract available
     
     
     
153. DE MEULEMEESTER J, Keymeulen B, De Block C, Van Huffel L, et al
     One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study.
     Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06366.
     PubMed     Abstract available
     
     
     
154. KOWALL B, Rathmann W
     Partnership and marriage and risk of type 2 diabetes: a narrative review.
     Diabetologia. 2025 Feb 7. doi: 10.1007/s00125-025-06360.
     PubMed     Abstract available
     
     
     
155. LIN YK, Ye W, Hepworth E, Agni A, et al
     Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.
     Diabetologia. 2025;68:433-443.
     PubMed     Abstract available
     
     
     
156. HANSEN AL, Christiansen CF, Brons C, Engelhard LM, et al
     Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort.
     Diabetologia. 2025 Feb 1. doi: 10.1007/s00125-024-06357.
     PubMed     Abstract available
     
     
     January 2025
157. FAN KS, Manoli A, Baumann PM, Shojaee-Moradie F, et al
     Comparison of continuous glucose monitoring with self-monitoring of blood glucose in type 1 diabetes in the changing atmospheric pressures in aviation: a hypobaric flight simulation.
     Diabetologia. 2025 Jan 31. doi: 10.1007/s00125-025-06364.
     PubMed     Abstract available
     
     
     
158. ZHUANG S, Sun N, Qu J, Chen Q, et al
     High glucose/ChREBP-induced Hif-1alpha transcriptional activation in CD4(+) T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response.
     Diabetologia. 2025 Jan 30. doi: 10.1007/s00125-024-06354.
     PubMed     Abstract available
     
     
     
159. FLOYD JL, Prasad R, Dupont MD, Adu-Rutledge Y, et al
     Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes.
     Diabetologia. 2025 Jan 28. doi: 10.1007/s00125-024-06349.
     PubMed     Abstract available
     
     
     
160. MUELLER J, Breeze P, Fusco F, Sharp SJ, et al
     Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagn
     Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06355.
     PubMed     Abstract available
     
     
     
161. COLLINS J, Farnsworth NL
     Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.
     Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06356.
     PubMed     Abstract available
     
     
     
162. MENDOZA K, Barquera S, Tobias DK
     Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions.
     Diabetologia. 2025 Jan 18. doi: 10.1007/s00125-025-06358.
     PubMed     Abstract available
     
     
     
163. LINGVAY I, Benamar M, Chen L, Fu A, et al
     Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
     Diabetologia. 2025 Jan 17. doi: 10.1007/s00125-024-06348.
     PubMed     Abstract available
     
     
     
164. CHEN Z, Qian F, Liu B, Zong G, et al
     Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women.
     Diabetologia. 2025 Jan 14. doi: 10.1007/s00125-024-06353.
     PubMed     Abstract available
     
     
     
165. PACHECO LS, Tobias DK, Haslam DE, Drouin-Chartier JP, et al
     Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults.
     Diabetologia. 2025 Jan 8. doi: 10.1007/s00125-024-06351.
     PubMed     Abstract available
     
     
     
166. HIRVELA L, Haukka J, Keski-Rahkonen A, Sipila PN, et al
     Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort.
     Diabetologia. 2025 Jan 4. doi: 10.1007/s00125-024-06346.
     PubMed     Abstract available
     
     
     
167. CHIMIENTI R, Torchio S, Siracusano G, Zamarian V, et al
     A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.
     Diabetologia. 2025;68:128-151.
     PubMed     Abstract available
     
     
     
168. FU Q, Dai H, Shen S, He Y, et al
     Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function.
     Diabetologia. 2025;68:116-127.
     PubMed     Abstract available
     
     
     
169. AHN M, Dhawan S, McCown EM, Garcia PA, et al
     Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
     Diabetologia. 2025;68:152-165.
     PubMed     Abstract available
     
     
     December 2024
170. NADEAU KJ, Arslanian SA, Bacha F, Caprio S, et al
     Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.
     Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06327.
     PubMed     Abstract available
     
     
     
171. COLE A, Weight N, Misra S, Grapsa J, et al
     Correction: Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
     Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06337.
     PubMed    
     
     
     
172. SHAPIRO MR, Tallon EM, Brown ME, Posgai AL, et al
     Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
     Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06339.
     PubMed     Abstract available
     
     
     
173. WERNROTH ML, Kennedy B, Fall K, Nguyen D, et al
     Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.
     Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06340.
     PubMed     Abstract available
     
     
     
174. BITARAFAN V, Anjom-Shoae J, Rezaie P, Fitzgerald PCE, et al
     Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study.
     Diabetologia. 2024 Dec 18. doi: 10.1007/s00125-024-06344.
     PubMed     Abstract available
     
     
     
175. KRISTENSEN FPB, Domazet SL, Nielsen JS, Stidsen JV, et al
     Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
     Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06342.
     PubMed     Abstract available
     
     
     
176. PERKINS BA, Turner LV, Riddell MC
     Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes.
     Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06317.
     PubMed    
     
     
     
177. SMEIJER JD, de Vries ST, Kohan DE, Hou FF, et al
     Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
     Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06326.
     PubMed     Abstract available
     
     
     
178. DE VRIES ST, Pena MJ, Tye SC, Peters SAE, et al
     Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
     Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325.
     PubMed     Abstract available
     
     
     
179. MOSER O, Zaharieva DP, Adolfsson P, Battelino T, et al
     The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPA
     Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06308.
     PubMed     Abstract available
     
     
     
180. BROWN ME, Thirawatananond P, Peters LD, Kern EJ, et al
     Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.
     Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329.
     PubMed     Abstract available
     
     
     
181. MACKENBACH JD, Stuber JM, Beulens JWJ
     Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.
     Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06330.
     PubMed     Abstract available
     
     
     
182. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
     A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
     Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06334.
     PubMed     Abstract available
     
     
     
183. VIRTANEN JK, Hantunen S, Kallio N, Lamberg-Allardt C, et al
     The effect of vitamin D(3) supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial.
     Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06336.
     PubMed     Abstract available
     
     
     
184. CHEN Y, Torta F, Koh HWL, Benke PI, et al
     Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
     Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06324.
     PubMed     Abstract available
     
     
     
185. ZEMSKI BERRY KA, Garfield A, Jambal P, Zarini S, et al
     Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle.
     Diabetologia. 2024;67:2819-2832.
     PubMed     Abstract available
     
     
     
186. WAT LW, Svensson KJ
     Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.
     Diabetologia. 2024;67:2626-2636.
     PubMed     Abstract available
     
     
     November 2024
187. TRICO D, Sacchetta L, Rebelos E, Cimbalo N, et al
     Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications.
     Diabetologia. 2024 Nov 29. doi: 10.1007/s00125-024-06312.
     PubMed     Abstract available
     
     
     
188. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
     Correction: Quantifying beta cell function in the preclinical stages of type 1 diabetes.
     Diabetologia. 2024 Nov 27. doi: 10.1007/s00125-024-06335.
     PubMed    
     
     
     
189. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
     Correction: A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
     Diabetologia. 2024 Nov 25. doi: 10.1007/s00125-024-06332.
     PubMed    
     
     
     
190. O CK, Fan B, Tsoi STF, Tam CHT, et al
     A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
     Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320.
     PubMed     Abstract available
     
     
     
191. GALDERISI A, Sims EK, Evans-Molina C, Petrelli A, et al
     Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
     Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06323.
     PubMed     Abstract available
     
     
     
192. LAESSER CI, Piazza C, Schorno N, Nick F, et al
     Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.
     Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06319.
     PubMed     Abstract available
     
     
     
193. YU G, Tam CHT, Lim CKP, Shi M, et al
     Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
     Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06309.
     PubMed     Abstract available
     
     
     
194. ROONEY MR, Wallace AS, Echouffo Tcheugui JB, Fang M, et al
     Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
     Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06315.
     PubMed     Abstract available
     
     
     
195. PHILLIPS NE, Mareschal J, Biancolin AD, Sinturel F, et al
     The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
     Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06318.
     PubMed     Abstract available
     
     
     
196. WANG E, Patorno E, Khosrow-Khavar F, Crystal S, et al
     Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
     Diabetologia. 2024 Nov 8. doi: 10.1007/s00125-024-06321.
     PubMed     Abstract available
     
     
     
197. AMR RA, Al-Smadi AM, Akasheh RT
     Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06304.
     PubMed     Abstract available
     
     
     
198. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
     Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06314.
     PubMed    
     
     
     
199. 
     Correction: 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes, Madrid, Spain, 9-13 September 2024. 'Average glucose and HbA(1c) display a nonlinear and variable relationship: implications for clinical practice'.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06294.
     PubMed    
     
     
     
200. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
     Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06316.
     PubMed     Abstract available
     
     
     
201. GOTTMANN P, Speckmann T, Stadion M, Chawla P, et al
     Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06301.
     PubMed     Abstract available
     
     
     
202. RAO C, Cater DT, Roy S, Xu J, et al
     Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8(+) T cell activity and biomarker during the evolution of type 1 diabetes.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06313.
     PubMed     Abstract available
     
     
     
203. MA RCW, Tam CHT, Hou Y, Lau ESH, et al
     NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.
     Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06299.
     PubMed     Abstract available
     
     
     
204. GESUITA R, Eckert AJ, Besancon S, Crimmins NA, et al
     Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry.
     Diabetologia. 2024 Nov 6. doi: 10.1007/s00125-024-06283.
     PubMed     Abstract available
     
     
     
205. MEIER DT, de Paula Souza J, Donath MY
     Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity.
     Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06306.
     PubMed     Abstract available
     
     
     
206. GARDEN GL, Fan KS, Paterson M, Shojaee-Moradie F, et al
     Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
     Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06295.
     PubMed     Abstract available
     
     
     
207. GLINTBORG D, Christensen LL, Andersen MS
     Transgender healthcare: metabolic outcomes and cardiovascular risk.
     Diabetologia. 2024;67:2393-2403.
     PubMed     Abstract available
     
     
     
208. 
     EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
     Diabetologia. 2024;67:2375-2392.
     PubMed     Abstract available
     
     
     October 2024
209. HOSTRUP PE, Schmidt T, Hellsten SB, Gerwig RH, et al
     Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial.
     Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06290.
     PubMed     Abstract available
     
     
     
210. TSAI YH, OjiNjideka Hemphill N, Kurth T
     Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications.
     Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06300.
     PubMed    
     
     
     
211. VOETS PJGM
     A modified total body water deficit formula for use in diabetes care.
     Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06311.
     PubMed    
     
     
     
212. HANNA SJ, Bonami RH, Corrie B, Westley M, et al
     The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium.
     Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06298.
     PubMed     Abstract available
     
     
     
213. SANTOSO C, Wei Y, Ahlqvist E, Tuomi T, et al
     Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.
     Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06303.
     PubMed     Abstract available
     
     
     
214. EDSTORP J, Rossides M, Ahlqvist E, Alfredsson L, et al
     Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study.
     Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06302.
     PubMed     Abstract available
     
     
     
215. NATHANSON D, Eeg-Olofsson K, Spelman T, Bulow E, et al
     Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies.
     Diabetologia. 2024 Oct 26. doi: 10.1007/s00125-024-06289.
     PubMed     Abstract available
     
     
     
216. MALLONE R
     Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
     Diabetologia. 2024 Oct 24. doi: 10.1007/s00125-024-06296.
     PubMed    
     
     
     
217. CHILUNGA FP, Mkoma GF
     GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap.
     Diabetologia. 2024 Oct 21. doi: 10.1007/s00125-024-06297.
     PubMed    
     
     
     
218. APAOLAZA PS, Chen YC, Grewal K, Lurz Y, et al
     Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
     Diabetologia. 2024 Oct 15. doi: 10.1007/s00125-024-06275.
     PubMed     Abstract available
     
     
     
219. CERIELLO A, Prattichizzo F, Berra C
     Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications.
     Diabetologia. 2024 Oct 4. doi: 10.1007/s00125-024-06284.
     PubMed    
     
     
     
220. COLE A, Weight N, Mishra S, Grapsa J, et al
     Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
     Diabetologia. 2024 Oct 3. doi: 10.1007/s00125-024-06281.
     PubMed     Abstract available
     
     
     
221. ZHAO LP, Papadopoulos GK, Skyler JS, Pugliese A, et al
     Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.
     Diabetologia. 2024 Oct 1. doi: 10.1007/s00125-024-06274.
     PubMed     Abstract available
     
     
     
222. OKURA T, Ito Y, Anno M, Endo S, et al
     Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
     Diabetologia. 2024;67:2304-2315.
     PubMed     Abstract available
     
     
     
223. YAMAGUCHI M, Nakao S, Arima M, Little K, et al
     Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.
     Diabetologia. 2024;67:2329-2345.
     PubMed     Abstract available
     
     
     
224. WU Y, Yang M, Wu SB, Luo PQ, et al
     Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.
     Diabetologia. 2024;67:2346-2366.
     PubMed     Abstract available
     
     
     
225. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
     Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
     Diabetologia. 2024;67:2210-2224.
     PubMed     Abstract available
     
     
     
226. GRENKO CM, Taylor HJ, Bonnycastle LL, Xue D, et al
     Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h.
     Diabetologia. 2024;67:2246-2259.
     PubMed     Abstract available
     
     
     September 2024
227. LIU S, Zhu J, Zhong H, Wu C, et al
     Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations.
     Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06277.
     PubMed     Abstract available
     
     
     
228. SHARMA S, Dong Q, Haid M, Adam J, et al
     Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
     Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06282.
     PubMed     Abstract available
     
     
     
229. HOLMAN N, Yelland AC, Young B, Valabhji J, et al
     Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management.
     Diabetologia. 2024 Sep 27. doi: 10.1007/s00125-024-06262.
     PubMed     Abstract available
     
     
     
230. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
     A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
     Diabetologia. 2024 Sep 21. doi: 10.1007/s00125-024-06272.
     PubMed     Abstract available
     
     
     
231. ELBARBARY NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, et al
     The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
     Diabetologia. 2024 Sep 14. doi: 10.1007/s00125-024-06265.
     PubMed     Abstract available
     
     
     
232. TSATSARIS G, Rajamand Ekberg N, Fall T, Catrina SB, et al
     Risk factors for Charcot foot development in individuals with diabetes mellitus.
     Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06271.
     PubMed     Abstract available
     
     
     
233. HEIKKILA TE, Kaiser EK, Lin J, Gill D, et al
     Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study.
     Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06267.
     PubMed     Abstract available
     
     
     
234. LAVENS A, De Block C, Oriot P, Crenier L, et al
     Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.
     Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06273.
     PubMed     Abstract available
     
     
     
235. 
     60(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Madrid, Spain, 9 - 13 September 2024.
     Diabetologia. 2024 Sep 12. doi: 10.1007/s00125-024-06226.
     PubMed    
     
     
     
236. GALINDO RJ, Soliman D, Chernavvsky D, Rhee CM, et al
     Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease.
     Diabetologia. 2024 Sep 10. doi: 10.1007/s00125-024-06278.
     PubMed    
     
     
     
237. LENZEN S
     Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes.
     Diabetologia. 2024 Sep 7. doi: 10.1007/s00125-024-06264.
     PubMed    
     
     
     
238. SORIA-CONTRERAS DC, Wang S, Liu J, Lawn RB, et al
     Lifetime history of gestational diabetes and cognitive function in parous women in midlife.
     Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06270.
     PubMed     Abstract available
     
     
     
239. WACHOWSKI NA, Pippin JA, Boehm K, Lu S, et al
     Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C.
     Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06261.
     PubMed     Abstract available
     
     
     
240. EIZIRIK DL, Zimath PL, Yi X, Roca Rivada A, et al
     Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter].
     Diabetologia. 2024 Sep 5. doi: 10.1007/s00125-024-06269.
     PubMed    
     
     
     
241. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
     Correction to: Consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
     Diabetologia. 2024 Sep 4. doi: 10.1007/s00125-024-06266.
     PubMed    
     
     
     
242. THOMSON RL, Brown JD, Oakey H, Palmer K, et al
     Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study.
     Diabetologia. 2024 Sep 2. doi: 10.1007/s00125-024-06259.
     PubMed     Abstract available
     
     
     
243. ESSER N, Hogan MF, Templin AT, Akter R, et al
     The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.
     Diabetologia. 2024;67:1897-1911.
     PubMed     Abstract available
     
     
     
244. LITHOVIUS V, Lahdenpohja S, Ibrahim H, Saarimaki-Vire J, et al
     Non-invasive quantification of stem cell-derived islet graft size and composition.
     Diabetologia. 2024;67:1912-1929.
     PubMed     Abstract available
     
     
     
245. WREVEN E, Ruiz de Adana MS, Hardiville S, Gmyr V, et al
     Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
     Diabetologia. 2024;67:1877-1896.
     PubMed     Abstract available
     
     
     
246. MAKINEN S, Sree S, Ala-Nisula T, Kultalahti H, et al
     Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
     Diabetologia. 2024;67:1943-1954.
     PubMed     Abstract available
     
     
     August 2024
247. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
     Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE).
     Diabetologia. 2024 Aug 31. doi: 10.1007/s00125-024-06252.
     PubMed     Abstract available
     
     
     
248. MALLIK R, Kar P, Mulder H, Krook A, et al
     The future is here: an overview of technology in diabetes.
     Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06235.
     PubMed    
     
     
     
249. SCIBILIA R, Breslin-Brooker N, Bright C, Dzikiti T, et al
     Global experiences and personal narratives on diabetes technology and access.
     Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06230.
     PubMed    
     
     
     
250. LIN DS, Lee JK, Huang KC, Lin TT, et al
     Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
     Diabetologia. 2024 Aug 29. doi: 10.1007/s00125-024-06257.
     PubMed     Abstract available
     
     
     
251. FADINI GP, Longato E, Morieri ML, Bonora E, et al
     Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
     Diabetologia. 2024 Aug 23. doi: 10.1007/s00125-024-06251.
     PubMed     Abstract available
     
     
     
252. TANABE H, Sato M, Miyake A, Shimajiri Y, et al
     Machine learning-based reproducible prediction of type 2 diabetes subtypes.
     Diabetologia. 2024 Aug 21. doi: 10.1007/s00125-024-06248.
     PubMed     Abstract available
     
     
     
253. KHUNTI K, Zaccardi F, Amod A, Aroda VR, et al
     Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.
     Diabetologia. 2024 Aug 19. doi: 10.1007/s00125-024-06254.
     PubMed     Abstract available
     
     
     
254. LEHNER CT, Schauberger G, Klug SJ
     Reduced type 2 diabetes incidence reflecting end of post?World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter].
     Diabetologia. 2024 Aug 17. doi: 10.1007/s00125-024-06255.
     PubMed    
     
     
     
255. PERKINS BA, Turner LV, Riddell MC
     Applying technologies to simplify strategies for exercise in type 1 diabetes.
     Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06229.
     PubMed     Abstract available
     
     
     
256. NILSSON PM, Vaag A
     Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany.
     Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06195.
     PubMed    
     
     
     
257. ADEBEKUN J, Nadig A, Saarah P, Asgari S, et al
     Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts.
     Diabetologia. 2024 Aug 14. doi: 10.1007/s00125-024-06247.
     PubMed     Abstract available
     
     
     
258. SMITH K, Taylor GS, Peeters W, Walker M, et al
     Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
     Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06249.
     PubMed     Abstract available
     
     
     
259. MALTESE G, McAuley SA, Trawley S, Sinclair AJ, et al
     Ageing well with diabetes: the role of technology.
     Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06240.
     PubMed     Abstract available
     
     
     
260. ELEFTHERIADOU A, Spallone V, Tahrani AA, Alam U, et al
     Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.
     Diabetologia. 2024 Aug 9. doi: 10.1007/s00125-024-06242.
     PubMed     Abstract available
     
     
     
261. GALINDO RJ, Soliman D, Chernasvvky D, Rhee CM, et al
     Diabetes technology in people with diabetes and advanced chronic kidney disease.
     Diabetologia. 2024 Aug 8. doi: 10.1007/s00125-024-06244.
     PubMed     Abstract available
     
     
     
262. YOU L, Ferrat LA, Oram RA, Parikh HM, et al
     Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.
     Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06246.
     PubMed     Abstract available
     
     
     
263. HAUKKA JK, Antikainen AA, Valo E, Syreeni A, et al
     Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.
     Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06241.
     PubMed     Abstract available
     
     
     
264. HURTADO I, Robles C, Peiro S, Garcia-Sempere A, et al
     Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.
     Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06243.
     PubMed     Abstract available
     
     
     
265. RASHID R, Chaudhry D, Evison F, Sharif A, et al
     Mortality risk for kidney transplant candidates with diabetes: a population cohort study.
     Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06245.
     PubMed     Abstract available
     
     
     
266. 
     Up Front.
     Diabetologia. 2024;67:1453-1454.
     PubMed    
     
     
     
267. VISA M, Berggren PO
     Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca(2+) dynamics in prediabetic beta cells.
     Diabetologia. 2024;67:1663-1682.
     PubMed     Abstract available
     
     
     
268. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
     Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
     Diabetologia. 2024;67:1588-1601.
     PubMed     Abstract available
     
     
     
269. WINTHER-SORENSEN M, Garcia SL, Bartholdy A, Ottenheijm ME, et al
     Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
     Diabetologia. 2024;67:1602-1615.
     PubMed     Abstract available
     
     
     July 2024
270. MASALIN S, Klavus A, Rono K, Koistinen HA, et al
     Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight.
     Diabetologia. 2024 Jul 31. doi: 10.1007/s00125-024-06237.
     PubMed     Abstract available
     
     
     
271. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
     The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
     Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06233.
     PubMed     Abstract available
     
     
     
272. EHRMANN D, Hermanns N, Schmitt A, Klinker L, et al
     Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses.
     Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06239.
     PubMed     Abstract available
     
     
     
273. VERNSTROM L, Gullaksen S, Sorensen SS, Ringgaard S, et al
     Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
     Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06228.
     PubMed     Abstract available
     
     
     
274. LUNDGAARD AT, Westergaard D, Roder T, Burgdorf KS, et al
     Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study.
     Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06231.
     PubMed     Abstract available
     
     
     
275. MOLVEAU J, Myette-Cote E, Tagougui S, Taleb N, et al
     Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial.
     Diabetologia. 2024 Jul 29. doi: 10.1007/s00125-024-06234.
     PubMed     Abstract available
     
     
     
276. KONDO A, McGrady M, Nallapothula D, Ali H, et al
     Spatial proteomics of human diabetic kidney disease, from health to class III.
     Diabetologia. 2024 Jul 22. doi: 10.1007/s00125-024-06210.
     PubMed     Abstract available
     
     
     
277. DONOVAN LE, Bell RC, Feig DS, Lemieux P, et al
     Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
     Diabetologia. 2024 Jul 19. doi: 10.1007/s00125-024-06227.
     PubMed     Abstract available
     
     
     
278. DU S, Sullivan VK, Fang M, Appel LJ, et al
     Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
     Diabetologia. 2024 Jul 13. doi: 10.1007/s00125-024-06221.
     PubMed     Abstract available
     
     
     
279. SCULLY KJ, Marks BE, Putman MS
     Advances in diabetes technology to improve the lives of people with cystic fibrosis.
     Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
     PubMed     Abstract available
     
     
     
280. SCHOELWER MJ, DeBoer MD, Breton MD
     Use of diabetes technology in children.
     Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
     PubMed     Abstract available
     
     
     
281. WANG W, Bain SC, Bian F, Chen R, et al
     Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
     Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
     PubMed     Abstract available
     
     
     
282. JI L, Agesen RM, Bain SC, Fu F, et al
     Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
     Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
     PubMed     Abstract available
     
     
     
283. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
     Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
     Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
     PubMed     Abstract available
     
     
     
284. BROZZI F, Jacovetti C, Cosentino C, Menoud V, et al
     tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
     Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06207.
     PubMed     Abstract available
     
     
     
285. DE WIT DF, Fuhri Snethlage CM, Rampanelli E, Maasen K, et al
     Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes.
     Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06213.
     PubMed     Abstract available
     
     
     
286. MCLEAN A, Maple-Brown L, Murphy HR
     Technology advances in diabetes pregnancy: right technology, right person, right time.
     Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06216.
     PubMed     Abstract available
     
     
     
287. DONNELLY LA, McCrimmon RJ, Pearson ER
     Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
     Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06217.
     PubMed     Abstract available
     
     
     
288. THABIT H, Schofield J
     Technology in the management of diabetes in hospitalised adults.
     Diabetologia. 2024 Jul 2. doi: 10.1007/s00125-024-06206.
     PubMed     Abstract available
     
     
     
289. 
     Up Front.
     Diabetologia. 2024;67:1163-1164.
     PubMed    
     
     
     
290. GYLFE E, Tengholm A
     Bo Hellman, 19 June 1930-4 December 2023.
     Diabetologia. 2024;67:1165-1167.
     PubMed    
     
     
     
291. BRAKENRIDGE CJ, Koster A, de Galan BE, Carver A, et al
     Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study.
     Diabetologia. 2024;67:1356-1367.
     PubMed     Abstract available
     
     
     
292. HTOO PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al
     Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
     Diabetologia. 2024;67:1328-1342.
     PubMed     Abstract available
     
     
     June 2024
293. LIARAKOS AL, Lim JZM, Leelarathna L, Wilmot EG, et al
     The use of technology in type 2 diabetes and prediabetes: a narrative review.
     Diabetologia. 2024 Jun 29. doi: 10.1007/s00125-024-06203.
     PubMed     Abstract available
     
     
     
294. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
     Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
     Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
     PubMed    
     
     
     
295. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
     Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
     Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
     PubMed     Abstract available
     
     
     
296. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
     Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
     Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
     PubMed     Abstract available
     
     
     
297. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
     Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
     Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
     PubMed     Abstract available
     
     
     
298. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
     The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
     Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
     PubMed     Abstract available
     
     
     
299. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
     Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
     Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
     PubMed     Abstract available
     
     
     
300. D'ALESSIO DA, Kahn SE, Mulder H
     The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
     Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
     PubMed    
     
     
     
301. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
     Hyperglycaemic crises in adults with diabetes: a consensus report.
     Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
     PubMed     Abstract available
     
     
     
302. MUTHUKUMAR A, Badawy L, Mangelis A, Vas P, et al
     HbA(1c) variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes.
     Diabetologia. 2024 Jun 20. doi: 10.1007/s00125-024-06197.
     PubMed     Abstract available
     
     
     
303. GAO L, Ramirez FJ, Cabrera JTO, Varghese MV, et al
     eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
     Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201.
     PubMed     Abstract available
     
     
     
304. KOBAYASHI Y, Long J, Johannsen NM, Talamoa R, et al
     Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? Reply to Pontes?Silva A, Santos?de?Araujo AD, Teixeira BC et al [letter].
     Diabetologia. 2024 Jun 18. doi: 10.1007/s00125-024-06181.
     PubMed    
     
     
     
305. WU M, Yoon CY, Park J, Kim G, et al
     The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
     Diabetologia. 2024 Jun 15. doi: 10.1007/s00125-024-06191.
     PubMed     Abstract available
     
     
     
306. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
     Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
     Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
     PubMed    
     
     
     
307. GUDEMANN LM, Young KG, Thomas NJM, Hopkins R, et al
     Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
     Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190.
     PubMed     Abstract available
     
     
     
308. VATANEN T, de Beaufort C, Marcovecchio ML, Overbergh L, et al
     Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
     Diabetologia. 2024 Jun 4. doi: 10.1007/s00125-024-06192.
     PubMed     Abstract available
     
     
     May 2024
309. ZHANG J, Zhang R, Liu C, Ge X, et al
     Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.
     Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06186.
     PubMed     Abstract available
     
     
     
310. SINGH T, Weiss A, Vehik K, Krischer J, et al
     Caesarean section and risk of type 1 diabetes.
     Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06176.
     PubMed     Abstract available
     
     
     
311. JEVON D, Cottle L, Hallahan N, Harwood R, et al
     Capillary contact points determine beta cell polarity, control secretion and are disrupted in the db/db mouse model of diabetes.
     Diabetologia. 2024 May 30. doi: 10.1007/s00125-024-06180.
     PubMed     Abstract available
     
     
     
312. GROEGLER J, Callebaut A, James EA, Delong T, et al
     The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
     Diabetologia. 2024 May 29. doi: 10.1007/s00125-024-06164.
     PubMed     Abstract available
     
     
     
313. SALVATORI B, Wegener S, Kotzaeridi G, Herding A, et al
     Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
     Diabetologia. 2024 May 27. doi: 10.1007/s00125-024-06184.
     PubMed     Abstract available
     
     
     
314. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
     The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
     Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
     PubMed     Abstract available
     
     
     
315. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
     Heterogeneity of glycaemic phenotypes in type 1 diabetes.
     Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
     PubMed     Abstract available
     
     
     
316. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
     Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
     Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
     PubMed    
     
     
     
317. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
     Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
     Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
     PubMed     Abstract available
     
     
     
318. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
     Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
     Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
     PubMed     Abstract available
     
     
     
319. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
     Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
     Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
     PubMed    
     
     
     
320. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
     Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
     Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
     PubMed     Abstract available
     
     
     
321. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
     Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
     Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
     PubMed     Abstract available
     
     
     
322. DEL PRATO S, Torbeyns B, Mathieu C
     2024: The year to take European action on diabetes to the next level.
     Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06166.
     PubMed    
     
     
     
323. SHEU A, White CP, Center JR
     Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
     Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
     PubMed     Abstract available
     
     
     
324. IBRAHIM H, Balboa D, Saarimaki-Vire J, Montaser H, et al
     RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.
     Diabetologia. 2024 May 14. doi: 10.1007/s00125-024-06163.
     PubMed     Abstract available
     
     
     
325. BOUGHTON CK, Hovorka R
     The role of automated insulin delivery technology in diabetes.
     Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06165.
     PubMed     Abstract available
     
     
     
326. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
     Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sanchez?Hernandez and Wagner [letter].
     Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06174.
     PubMed    
     
     
     
327. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
     Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
     Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167.
     PubMed    
     
     
     
328. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
     New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
     Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
     PubMed    
     
     
     
329. RAUSCHER FG, Elze T, Francke M, Martinez-Perez ME, et al
     Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
     Diabetologia. 2024;67:928-939.
     PubMed     Abstract available
     
     
     
330. RUISSEN MM, Steyerberg EW, Huisman SD, de Graaf AA, et al
     Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschenes SS [letter].
     Diabetologia. 2024;67:956-957.
     PubMed    
     
     
     
331. POUWER F, Deschenes S
     Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention.
     Diabetologia. 2024;67:954-955.
     PubMed    
     
     
     
332. IDEVALL-HAGREN O, Incedal Nilsson C, Sanchez G
     Keeping pace: the primary cilium as the conducting baton of the islet.
     Diabetologia. 2024;67:773-782.
     PubMed     Abstract available
     
     
     April 2024
333. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
     Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
     Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
     PubMed    
     
     
     
334. TREVISAN R, Conti M, Ciardullo S
     Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
     Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
     PubMed     Abstract available
     
     
     
335. CHEN J, Feng Q, Qiao Y, Pan S, et al
     ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
     Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
     PubMed     Abstract available
     
     
     
336. STERNER ISAKSSON S, Imberg H, Hirsch IB, Schwarcz E, et al
     Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
     Diabetologia. 2024 Apr 26. doi: 10.1007/s00125-024-06151.
     PubMed     Abstract available
     
     
     
337. TAYLOR GS, Smith K, Scragg J, McDonald TJ, et al
     The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
     Diabetologia. 2024 Apr 25. doi: 10.1007/s00125-024-06153.
     PubMed     Abstract available
     
     
     
338. DENICOLO S, Reinstadler V, Keller F, Thoni S, et al
     Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
     Diabetologia. 2024 Apr 22. doi: 10.1007/s00125-024-06149.
     PubMed     Abstract available
     
     
     
339. KIM JY, Jin SM, Sim KH, Kim BY, et al
     Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
     Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
     PubMed     Abstract available
     
     
     
340. KIM JY, Jin SM, Kang ES, Kwak SH, et al
     Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
     Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
     PubMed     Abstract available
     
     
     
341. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
     Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
     Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
     PubMed     Abstract available
     
     
     
342. SACCO S, Foschi M, Ornello R, De Santis F, et al
     Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
     Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
     PubMed     Abstract available
     
     
     
343. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
     Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
     Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
     PubMed     Abstract available
     
     
     
344. METSALA J, Risnes K, Persson M, Veijola R, et al
     Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
     Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
     PubMed     Abstract available
     
     
     
345. VALABHJI J, Holman N, Collins N, Young RJ, et al
     Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
     Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
     PubMed     Abstract available
     
     
     
346. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
     Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
     Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
     PubMed     Abstract available
     
     
     
347. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
     Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
     Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
     PubMed    
     
     
     
348. LIU B, Xie D, Huang X, Jin S, et al
     Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
     Diabetologia. 2024;67:724-737.
     PubMed     Abstract available
     
     
     
349. XIE C, Iroga P, Bound MJ, Grivell J, et al
     Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
     Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
     PubMed     Abstract available
     
     
     March 2024
350. KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
     Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
     Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
     PubMed     Abstract available
     
     
     
351. VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
     Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
     Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
     PubMed     Abstract available
     
     
     
352. MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
     The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
     Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
     PubMed     Abstract available
     
     
     
353. TURNER LV, Marak MC, Gal RL, Calhoun P, et al
     Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
     Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06127.
     PubMed     Abstract available
     
     
     
354. LUND-BLIX NA, Bjerregaard AA, Tapia G, Stordal K, et al
     No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts.
     Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06125.
     PubMed     Abstract available
     
     
     
355. GUSTAFSON D, DiStefano PV, Wang XF, Wu R, et al
     Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.
     Diabetologia. 2024 Mar 15. doi: 10.1007/s00125-024-06120.
     PubMed     Abstract available
     
     
     
356. MONTEYNE AJ, Falkenhain K, Whelehan G, Neudorf H, et al
     A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
     Diabetologia. 2024 Mar 14. doi: 10.1007/s00125-024-06122.
     PubMed     Abstract available
     
     
     
357. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
     Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
     Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
     PubMed     Abstract available
     
     
     February 2024
358. SU M, Hou Y, Cai S, Li W, et al
     Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
     Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
     PubMed     Abstract available
     
     
     
359. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
     Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
     Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
     PubMed     Abstract available
     
     
     
360. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
     Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
     Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
     PubMed     Abstract available
     
     
     
361. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
     Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
     Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
     PubMed     Abstract available
     
     
     
362. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
     Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
     Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
     PubMed     Abstract available
     
     
     
363. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
     Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
     Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
     PubMed     Abstract available
     
     
     
364. SANCHEZ-HERNANDEZ RM, Wagner AM
     Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
     Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.